BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 7, 2026
See today's BioWorld Asia
Home
» Other news to note for April 28, 2020
To read the full story,
subscribe
or
sign in
.
Other news to note for April 28, 2020
April 28, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Ablexis, Adamis, Adaptvac, Agastiya, Akshaya, Arcturus, Armagen, Audax Medical, Avacta, Bayer, Berkeley Lights, Bioaegis, Biosig, Biovista, Clover, Cocrystal, Cutia, Cyclica, Cytiva, Dynavax, Emergent Biosolutions, Epimab, Faron, Gilead, Hansoh, Hemogenyx, Hoth, Immunic, Imquest, Innovation, Insmed, JCR, Johnson & Johnson, Kamada, Kedrion, Linical, Menlo, Merck, Moleculin, Nascent, Nextgen Vaccines, Nikang, Novelstem, Opgen, Orifarm Group, Pharnext, Prothera, Q Biomed, Recce, Recursion, Redhill, Santhera, Scancell, Sengenics, Takeda, Tracon, Trilink, Valneva, Valo, Vaxart, Vertex, Viravaxx, Vivacelle, Voltron, Wize.
BioWorld Asia
Briefs
Other news to note